Cancer News

Baylor College of Medicine welcomes Dr. Chonghui ChengJun 24, 2016
Dr. Chonghui Cheng joins Baylor's Lester and Sue Smith Breast Center and the Department of Molecular and Human Genetics as an associate professor, continuing her work to explore how RNA regulation controls breast cancer metastasis.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
ASCO honors Osborne for work in breast cancer research, mentorshipJun 14, 2016
Dr. C Kent Osborne has been awarded the 2016 American Society of Clinical Oncology’s Gianni Bonadonna Breast Cancer Award and Lecture.
Mouse model shows that Notch activation can drive metastatic prostate cancerJun 13, 2016
Researchers find that in mouse models, Notch signaling promotes the ability of tumors to spread to other organs.
First-of-its-kind children’s cancer center launches in Botswana capitalJun 13, 2016
The Botswana-Baylor Children’s Center of Excellence and the government of Botswana began development of the first children’s hematology and cancer center of excellence in Gaborone.
Decrease your chances of developing skin cancerMay 26, 2016
A Baylor College of Medicine skin expert reminds us that no tan is a healthy tan but instead increases the risk of developing skin cancer.
Dan L Duncan Comprehensive Cancer Center researchers awarded CPRIT grants to support the fight against cancerMay 25, 2016
Three researchers from the Dan L Duncan Comprehensive Cancer Center at Baylor have been awarded academic research program grants from the Cancer Prevention and Research Institute of Texas.
First large-scale proteogenomic study of breast cancer provides insight into potential therapeutic targetsMay 25, 2016
Researchers completed the first large-scale “proteogenomic” study of breast cancer, linking DNA mutations to protein signaling and helping pinpoint the genes that drive cancer.
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapiesMay 19, 2016
Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment. 
Researchers uncover marker important to effectiveness of natural killer T cellsMay 16, 2016
Researchers identified a molecular marker of NKT cells that could lead to effective cancer immunotherapy.